NACFC 2020: How Genetic-Based Therapies Could Restore CFTR Function

Genetic-based therapies could restore the cystic fibrosis transmembrane conductance regulator (CFTR) function in people with CF. Learn more about several key types of lung cells that could be targeted by RNA therapy, gene therapy, and gene editing.

Originally presented as part of the Cystic Fibrosis Foundation's NACFC 2020.